Abstract
Far from the traditional view of selective drug-target interactions, the recent accumulation of large amounts of interaction data for small-molecule drugs and protein targets requires innovative visualisation and analysis tools that are able to deal with what has become a truly complex system. In this context, network theory offers both a robust and illustrative framework to investigate drugtarget connections and has been swiftly and widely embraced by the chemical biology and molecular informatics communities. A survey of the most recent applications of drug-target networks to detect cross-pharmacology relationships among targets and to identify new targets for known drugs is provided. Finally, some of the current limitations are also discussed, including the actual completeness of interaction data and the information loss intrinsically associated with the one-mode projection of drug-target networks.
| Original language | English |
|---|---|
| Pages (from-to) | 10-14 |
| Number of pages | 5 |
| Journal | Molecular Informatics |
| Volume | 29 |
| Issue number | 1-2 |
| DOIs | |
| Publication status | Published - 12 Jan 2010 |
| Externally published | Yes |
Keywords
- Affinity fingerprint
- Chemogenomics
- Drug design
- Drug repurposing
- Molecular evolution
- Polypharmacology
- Target profiling
Fingerprint
Dive into the research topics of 'Drug-target networks'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver